News|Articles|May 1, 2013

Applied Clinical Trials

  • Applied Clinical Trials-05-01-2013
  • Volume 22
  • Issue 5

Principal Investigators Take the Lead FDA-Regulated Studies

Tufts CSDD

The total number of active principal investigators (PIs) participating in FDA-regulated studies worldwide has reached a record high of 27,924 due to rising clinical trial volume and more individual sites conducting fewer trials each year. More than half (53%) of all FDA-regulated clinical trials are now conducted by independent, community based PIs—the first time this segment has taken the leading proportion globally. University, hospital, and government clinics have been gradually losing their market share—falling from about two-thirds of all global FDA-regulated investigators in 2006 to less than half (47%) of the total in 2012.

Figure 1. The percentage of community-based investigators is growing worldwide.

—Tufts Center for the Study of Drug Development, https://csdd.tufts.edu.

Articles in this issue

about 10 years ago

Applied Clinical Trials Digital Edition - May 2013

almost 13 years ago

Data Cleaning Cycle Times Are Improving, But There's Still A Long Way to Go

almost 13 years ago

The IDEAS Initiative

almost 13 years ago

Sponsors and Service Providers Share Their Experiences

almost 13 years ago

Optimizing Efficiency

almost 13 years ago

Data Cleaning Cycle Times Are Improving, But There's Still A Long Way to Go

almost 13 years ago

Improving Clinical Trial Enrollment Forecasts Using SORM

almost 13 years ago

Breaking Down Clinical Barriers

almost 13 years ago

ACT Cover

almost 13 years ago

CNS Drug Liabilities in Early Phase Clinical Trials

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content